Cytokinetics sec filings
WebFind the latest SEC Filings data for Cytokinetics, Incorporated Common Stock (CYTK) at Nasdaq.com. WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors.
Cytokinetics sec filings
Did you know?
WebThis will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, par value $0.001 per share, of Cytokinetics, Incorporated, a Delaware corporation, will be filed on behalf of … WebItem 1.01 Entry into a Material Definitive Agreement. On February 1, 2024, Cytokinetics, Incorporated ("Cytokinetics") entered into a Royalty Purchase Agreement (the "Royalty Agreement") with RPI Finance Trust ("RPI"), an entity related to Royalty Pharma.
WebFeb 22, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. … WebMay 16, 2024 · EX-99.1 CYTOKINETICS AND ROYALTY PHARMA ANNOUNCE $100 MILLION TRANSACTION FOR OMECAMTIV MECARBIL Royalty Pharma Buys 4.5 …
WebApr 8, 2024 · Cytokinetics Inc (CYTK) SEC Filing DEF 14A Proxy Statement Report for the fiscal year ending Tuesday, May 10, 2024. Home. SEC Filings. ... Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats. Last10K.com Member Feature. Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word (DOCX), … WebApr 10, 2024 · Cytokinetics To Participate In The 22nd Annual Needham Virtual Healthcare Conference. SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK ...
WebMar 31, 2024 · CYTK Cytokinetics, Incorporated SEC Filings 8.71K followers $35.19 0.98 ( +2.86%) 4:00 PM 03/31/23 NASDAQ $USD Post-Market: $35.70 +0.51 (+1.45%) 5:56 …
WebSep 30, 2024 · Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2024 Cytokinetics, … townhouse for sale swannanoa ncWebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. townhouse for sale tamihi way chilliwackWebJul 1, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in … townhouse for sale stuart flWebApr 13, 2024 · China Universal Asset Management Co. Ltd.’s holdings in Cytokinetics were worth $44,000 as of its most recent filing with the Securities & Exchange Commission. Several other large investors have also made changes to their positions in CYTK. Advisor Group Holdings Inc. lifted its position in shares of Cytokinetics by 14.9% in the first quarter. townhouse for sale sw sioux falls sdWebUnder the Securities Exchange Act of 1934 (AMENDMENT NO. 1) CYTOKINETICS, INCORPORATED (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER … townhouse for sale thousand oaksWebMar 27, 2024 · empowering muscle empowering lives. Cytokinetics is committed to our mission of developing potential medicines that may improve the healthspan of people living with cardiovascular and … townhouse for sale sydneyWebJan 9, 2024 · Filings & Forms All companies, foreign and domestic, are required to file registration statements, periodic reports, and other forms electronically through EDGAR. Anyone can access and download this information for free. Here you'll find links to a complete list of filings available through EDGAR and instructions for searching the … townhouse for sale tandang sora quezon city